Aethlon Medical Inc

NASDAQ:AEMD 3:59:40 PM EDT

0.38

0.00 (+0.50%)

Products, Regulatory

Aethlon Medical Announces Contract With Namsa To Advance Hemopurifier Clinical Programs In Cancer

Published: 01/30/2023 14:47 GMT

Aethlon Medical Inc (AEMD) - Aethlon Medical Announces Contract With Namsa to Advance Hemopurifier Clinical Programs in Cancer.
Aethlon Medical Inc - Namsa Will Manage Co's Study of Hemopurifier for Patients in United States and Australia With Various Types of Cancer Tumors.
Aethlon Medical Inc - Anticipated Initial Clinical Trials Will Begin in Australia.